Aurora Cannabis (ACB) Long-Term Debt Issuances (2018 - 2025)
Aurora Cannabis (ACB) reported Long-Term Debt Issuances of $3.0 million for Q1 2025, down 59.21% year-over-year from $7.4 million in Q1 2024, and up 318.33% quarter-over-quarter from $720860.1 in Q4 2024.
Aurora Cannabis (ACB) Long-Term Debt Issuances (2018 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has 8 years of Long-Term Debt Issuances data on file, last reported at $3.0 million in Q1 2025.
- Long-Term Debt Issuances for Q1 2025 came in at $3.0 million, down 59.21% year-over-year; the trailing twelve-month figure through Mar 2025 was $8.4 million (down 42.39% YoY), and the FY2025 annual result was $8.1 million, down 24.58% from the prior year.
- Long-Term Debt Issuances grew to $3.0 million in Q1 2025 per ACB's latest filing, from $720860.1 in the prior quarter.
- Over five years, Long-Term Debt Issuances peaked at $7.4 million in Q1 2024 and troughed at -$786989.4 in Q4 2021.
- A 5-year average of $1.8 million and a median of $668892.6 in 2021 frame the typical range for Long-Term Debt Issuances.
- The sharpest annual moves came in 2022 and 2023: Long-Term Debt Issuances jumped 577.13% in 2022, then sank 88.28% in 2023.
- A 5-year view of Long-Term Debt Issuances shows it stood at -$786989.4 in 2021, then jumped by 577.13% to $3.8 million in 2022, then slumped by 88.28% to $439986.8 in 2023, then jumped by 63.84% to $720860.1 in 2024, then soared by 318.33% to $3.0 million in 2025.
- Business Quant data shows ACB's Long-Term Debt Issuances at $3.0 million in Q1 2025, $720860.1 in Q4 2024, and $4.2 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Issuance (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.51 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 3.02 Mn |
| Mar 31, 2025 | 3.02 Mn |
| Dec 31, 2024 | 720,860.08 |
| Dec 31, 2024 | 720,860.08 |
| Sep 30, 2024 | 4.16 Mn |
| Sep 30, 2024 | 4.16 Mn |
| Jun 30, 2024 | 490,595.31 |
| Jun 30, 2024 | 490,595.31 |
| Mar 31, 2024 | 7.39 Mn |
| Mar 31, 2024 | 7.39 Mn |
| Dec 31, 2023 | 439,986.78 |
| Dec 31, 2023 | 439,986.78 |
| Sep 30, 2023 | 2.97 Mn |
| Sep 30, 2023 | 2.97 Mn |
| Dec 31, 2022 | 3.75 Mn |
| Dec 31, 2022 | 3.75 Mn |
| Sep 30, 2022 | 645,600.34 |
| Sep 30, 2022 | 645,600.34 |
| Jun 30, 2022 | -76,865.38 |
| Jun 30, 2022 | -76,865.38 |